氩氦刀联合化疗治疗中晚期老年非小细胞肺癌临床观察  

Clinical Observation of Cryosurgery Combined Chemotherapy on Advanced Senility no Small Cell Lung Cancer

作　　者：张彩霞[1] 崔洪霞[1] 王成[1] 

机构地区：[1]吉林省肿瘤医院,吉林长春130012

出　　处：《中国医药指南》2011年第20期208-209,共2页Guide of China Medicine

摘　　要：目的采用氩氦刀联合化疗治疗中晚期老年非小细胞肺癌,探讨其临床应用的可行性,观察近期疗效及安全性。方法选择62例老年中晚期非小细胞肺癌患者,经CT引导下行氩氦刀冷冻治疗,冷冻治疗后根据患者情况行NP、GP、TP方案化疗。结果治疗后3个月复查,CR 3例,PR 19例,SD 26例,CR+PR 22例,有效率37.5%(22/62),CR+PR+SD 48例,临床获益率77.4%(48/62)。1年生存率50%。结论氩氦刀冷冻治疗联合化疗治疗肺癌具有创伤性小,不良反应小、耐受性好、恢复快,疗效好等优点,不仅从影像学上观察到治疗效果,还可以明显提高生活质量,该方法为失去手术机会的老年中晚期非小细胞肺癌患者提供一种安全、有效的治疗方法。Objective Clinical observation of cryosurgery on advanced senility no small cell lung cancer.Methods 62 patients with unresectable advanced senility no small cell lung cancer were treated.Results 62 cases were review of after 3 months,CR 3 cases,PR 19 cases,SD 26 cases,PD 14 cases,CR＋PR 22 cases,overall rates 35%.CR＋PR＋SD 48cases,clinical benefit rates 77.4%（48/62）.Conclusion Cryotherapy combined chemotherapy is an effective methods for advanced senility no small cell lung cancer.Our findings indicate that Endocare CryocareTM surgical syetem is an effective and safe technique to treat advanced senility no small cell lung cancer and complication is little.

关 键 词：靶向消融 美国氩氦刀 非小细胞肺癌 老年 化疗 

分 类 号：R734.2[医药卫生—肿瘤]